<DOC>
	<DOCNO>NCT01192347</DOCNO>
	<brief_summary>This observational study explore different treatment regimen affect continuation treatment first 6 month follow initiation XAGRID adult patient ' essential thrombocythemia therapy .</brief_summary>
	<brief_title>French Observational Xagrid ( FOX ) Study In Adult Patients With Essential Thrombocythemia</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<criteria>Inclusion Criteria 1 . Patients age 18 year old . 2 . Highrisk ET Patients , uncontrolled firstline ( previous ) cytoreductive treatment efficacy tolerance reason . 3 . Patients second thirdline XAGRID treatment 1 month , decision document commence second line XAGRID treatment . 4 . Patients able understand able willing participate study , provide personally dated sign write informed consent form . Exclusion Criteria 1 . Patients know suspected intolerance hypersensitivity XAGRID , closely related compound , state ingredient . 2 . Patients intention treat combination cytoreductive therapy . 3 . Patients participate separate clinical trial treatment define study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>